Glutamate Transporter GLT-1 Upregulation Attenuates Visceral Nociception and Hyperalgesia via Spinal Mechanisms Not Related to Anti-Inflammatory or Probiotic Effects
Pain Research and Treatment · 2011
DOI: 10.1155/2011/507029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pain Research and Treatment, 2011. Verfasst von Y Lin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Cell Biology, The Ohio State University, Columbus, OH 43210, USA. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: NCRR NIH HHS, Ohio State University, National Institutes of Health.
Abstract (Originalsprache)
Visceral pain is the most common reason for physician visits in US. Glutamate is the major excitatory neurotransmitter and mediates visceral nociceptive neuro-transmission and hypersensitivity. Removal of extracellular glutamate is predominantly mediated by glial glutamate transporter-1 (GLT-1). The pharmacological approach to up-regulate GLT-1 by 1 week administration of ceftriaxone (CTX) has been successful to mitigate visceral nociception. The present study shows that intrathecal delivery of selective GLT-1 antagonist dihydrokainate reversed CTX-blunted visceral nociceptive response, suggesting a spinal site of action. The role of GLT-1 up-regulation in animal models of colitis was studied. CTX treatment reversed TNBS-induced visceral hypersensitivity. In addition, CTX treatment initiated one week after the onset of DSS-induced visceral inflammation also attenuated visceral hypersensitivity, revealing a potential therapeutic effect. Cephalothin, a cephalosporin antibiotic lacking GLT-1 induction activity, failed to attenuate visceral nociception. CTX-induced changes in fecal microbiota do not support a role of probiotic effects in mitigating visceral nociception/hypersensitivity. Finally, adeno-associated virus serotype 9-mediated GLT-1 over-expression was effective to mitigate visceromotor response to 60 mmHg colo-rectal distension. These studies indicate that GLT-1 over-expression is a novel and effective method to attenuate visceral nociception, and is deserving of further study as a translationally relevant approach to treat visceral pain.
Autor:innen und Institutionen
- Department of Physiology and Cell Biology, The Ohio State University, Columbus, OH 43210, USA.
Förderung
- NCRR NIH HHS
- Ohio State University
- National Institutes of Health
Zitieren
APA
Lin, Y., Roman, K., Foust, K. D., Kaspar, B. K., Bailey, M. T., & Stephens, R. L. (2011). Glutamate Transporter GLT-1 Upregulation Attenuates Visceral Nociception and Hyperalgesia via Spinal Mechanisms Not Related to Anti-Inflammatory or Probiotic Effects. Pain Research and Treatment. https://doi.org/10.1155/2011/507029
Vancouver
Lin Y, Roman K, Foust KD, Kaspar BK, Bailey MT, Stephens RL. Glutamate Transporter GLT-1 Upregulation Attenuates Visceral Nociception and Hyperalgesia via Spinal Mechanisms Not Related to Anti-Inflammatory or Probiotic Effects. Pain Research and Treatment. 2011. doi:10.1155/2011/507029
BibTeX
@article{Lin2011,
author = {Lin, Y and Roman, K and Foust, K D and Kaspar, B K and Bailey, M T and Stephens, R L},
title = {Glutamate Transporter GLT-1 Upregulation Attenuates Visceral Nociception and Hyperalgesia via Spinal Mechanisms Not Related to Anti-Inflammatory or Probiotic Effects},
journal = {Pain Research and Treatment},
year = {2011},
doi = {10.1155/2011/507029}
}
EUVIMED